glp-1/fgf21 agonist boehringer MASH field still hot as axes $870M deal with Yuhan Novel Therapies for Cardiometabolic Disease:
Pay in 4 interest-free payments of $7.39 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28



























